ABSTRACT DNA nanotechnology-based nanosystems and macrosystems have attracted much attention in the biomedical research field. The nature of DNA endows these systems with biodegradable, biocompatible, and immunomodulatory properties. Here, we present an injectable hydrogel system that consists only of chemically synthesized short DNA strands, water, and salts. Several preparations of polypod-like structured DNA, or polypodna, were designed, including tri-, tetra-, penta-and hexapodna, as the building blocks of self-gelling DNA hydrogel. Under physiological conditions, properly designed polypodna preparations formed a hydrogel. The analysis of the modulus data of the hydrogel consisting of two sets of hexapodna preparations showed that this injectable hydrogel was reorganized in a time scale of 0.25 s. Then, DNA hydrogel containing unmethylated cytosine-phosphate-guanine (CpG) dinucleotides was used to stimulate innate immunity through Toll-like receptor 9, the receptor for CpG DNA. Gel formation significantly increased the activity of immunostimulatory CpG DNA, retarded the clearance after intradermal injection into mice, and increased the immune responses to ovalbumin (OVA) incorporated into the hydrogel as a model antigen. OVA/CpG DNA hydrogel induced much less local or systemic adverse reactions than OVA injected with complete Freund's adjuvant or alum. GpC DNA hydrogel containing no CpG sequences was less effective, indicating the importance of immunomodulation by CpG DNA hydrogel. Thus, we have created an efficient system for sustained delivery of antigens or other bioactive compounds.
INTRODUCTION
nodes was extracted using Sepasol RNA I super (Nacalai Tesque). The extracted RNA was reverse-transcribed with a ReverTra Ace ® qPCR RT Kit (TOYOBO, Osaka, Japan). For quantitative analysis of mRNA expression, real-time PCR was conducted with total RNA using KAPA SYBR FAST ABI Prism 2X qPCR Master Mix (KAPA BIOSYSTEMS, Boston, MA, USA). The ODN primers used for amplification were as follows: IL-6, forward (5'-GTTCTCTGGGAAATCGTGGA-3') and reverse (5'-TGTACTCCAGGTAGCTATGG-3'); -actin, forward (5'-CATCCGTAAAGACCTCTA-TGC-3') and reverse (5'-ATGGAGCCACCGATCCACA-3'). Amplified products were detected online via intercalation of SYBR Green, a fluorescent dye, by using StepOnePlus Real Time PCR System (Applied Biosystems, Foster City, CA, USA). The IL-6 mRNA expression was normalized to the mRNA level of -actin.
OVA release from DNA hydrogel. OVA (albumin from chicken egg white, Sigma-Aldrich) was labeled with fluorescein isothiocyanate (FITC; fluorescein isothiocyanate isomer 1, SigmaAldrich) to obtain FITC-OVA. FITC-OVA was added to both hexapodna solutions and DNA hydrogel was prepared by mixing the solutions. Then, FITC-OVA/DNA hydrogel (10 l) was placed into the upper chamber of the Transwell (Product#3460, 0.4 m pore size, Corning Inc., Corning, NY, USA), and 500 l PBS was added into the bottom chamber, and incubated at 37 C. At predetermined time points, bright field and fluorescence images of FITC-OVA/DNA hydrogel were obtained using LAS3000 system (Fujifilm, Tokyo, Japan), and the receiver solution was collected and replaced with 500 l fresh PBS. The fluorescence intensity of the receiver solution was measured in a Wallac 1420 ARVO MX-2 Multilabel Counter (Perkin Elmer, Boston, MA, USA).
Degradation of DNA hydrogel by DNase. Hexapodna preparations (220 μg/100 μl) were incubated at 37 C in the presence of DNase Ӏ (0.002 U/μg of DNA). At predetermined time points, a 10 μl aliquot of the sample solution was transferred to plastic tubes and mixed with 20 μl of 0.5 M EDTA solution to stop the degradation and then stored at -20 C until use. These samples were run on a 6 % PAGE and stained with ethidium bromide. The density of DNA bands was quantitatively evaluated using the Multi Gauge software (FUJIFILM, Tokyo, Japan). DNA hydrogel (220 μg/10 μl) was prepared in plastic tubes and incubated at 37 C after addition of solution containing DNase Ӏ (0.002 U/μg of DNA). At predetermined time points, supernatant was removed, and amount of remaining DNA was evaluated by measuring absorbance of 260 nm at 95 C.
Antigen presentation assay. To cultured DC2.4 cells were added DNA (2 g/ml) and OVA (2 mg/ml), then CD8OVA1.3 cells, then the mixture was incubated at 37 C in 5% CO 2 for an additional 24 h. The concentration of IL-2 in the supernatant was determined using an ELISA kit (mouse IL-2 BD OptEIA Set, BD Biosciences).
Immunization of mice.
Under anesthesia with isoflurane, the dorsal skin of C57BL/6 mice was injected with 50 g OVA in the presence or absence of 220 g DNA in 10 l saline or with complete Freund's adjuvant (CFA). Mice were immunized thrice on days 0, 7, and 14. Seven days after the last immunization, mice were killed and serum and the spleen were collected.
Measurement of OVA-specific antibody. Serum samples were serially diluted to measure the OVA-specific total IgG levels by ELISA as previously described [23] .
IFN- secretion from spleen cells. Seven days after the last immunization, spleen cells were isolated, purified and cultured in the presence of OVA (1 mg/ml) in 96-well culture plates for 4 days. The concentration of IFN- in supernatant was determined by ELISA (Ready-SET-Go! Mouse IFN- ELISA, eBioscience, San Diego, CA, USA).
Cytotoxic T lymphocyte assay. Seven days after the last immunization, spleen cells were isolated and purified as above. To prime CTLs, splenocytes were co-cultured with mitomycin Ctreated EG7-OVA cells for 5 days in 5% CO2 at 37 C. Target cells (EG7-OVA or EL4) were labeled with 51 Cr-sodium chromate (Na 2 51 CrO 4 , Fujifilm RI Pharma, Tokyo, Japan). Boosted splenocytes, effector cells, were serially diluted and co-incubated with the target cells for 4 h at 37 C. Then, the percentage of specific lysis was calculated as previously reported [20] .
Hematoxylin and eosin staining of skin sections. Under anesthesia with isoflurane, the dorsal skin of C57BL/6 mice was injected with 50 g OVA with or without 220 g DNA, CFA or 100 g alum (aluminum potassium sulfate dodecahydrate, Nacalai Tesque, Kyoto, Japan). Seven days after the immunization, the injection site was excised, fixed in 4% paraformaldehyde, embedded in paraffin, sliced and stained with hematoxylin and eosin. Stained samples were examined under a microscope for histological evaluation.
Measurement of spleen weight. Spleen was collected from different sets of C57BL/6 mice at seven days after the third immunization with weekly intervals. Spleen weight was measured as an indicator of splenomegaly, a systemic adverse effect of immunostimulatory compounds.
Statistical analysis. Statistical analyses were performed using Statview v. 5.0 (SAS Institute Inc., Cary, NC, USA). Statistical differences were analyzed using one-way analysis of variance (ANOVA) followed by Student-Newman-Keuls test. P values of 0.05 were considered significant.
RESULTS
Spontaneous formation of DNA hydrogel. Several sets of ODNs were designed to obtain polypodna preparations with three-(tripodna), four-(tetrapodna), or six-pods (hexapodna) ( Table  S1 ). The formation of these preparations was confirmed by polyacrylamide gel electrophoresis (PAGE) ( Figure S1 ). Two sets of four ODNs with 40-nucleotide (nt) length in total and 12-nt length of single stranded 5'-ends were used to obtain tetrapodna(CpG) 12p-28 -A and tetrapodna(CpG) 12np-28 -A, respectively, and these were visualized using propidium iodide (PI), an intercalating dye. A tetrapodna(CpG) 12p-28 -A having palindromic (p) 12-mer 5'-ends (5'-acgtcatgacgt-3') was soluble in a buffer solution containing 5 mM sodium chloride (Figure 1a , far left), and gelled upon drop wise addition into a solution containing physiological salt concentration (phosphate-buffered saline; 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 and 1.76 mM KH 2 PO 4 , pH, 7.4) (Figure 1a , third from left). Another tetrapodna, tetrapodna(CpG) 12np-28 -A, with non-palindromic (np) 12-mer 5'-ends (5'-acgtcagcgtta-3') diffused when added into the solution (Figure 1a, far right) . A typical field emission scanning electron microscopy image of the DNA hydrogel consisting of tetrapodna(CpG) 12p-28 -A clearly shows that the DNA hydrogel has an ordered structure with abundant space within the gel (Figure 1b) .
Hydrogel formation by mixing two polypodna preparations. The mixing of a polypodna and other DNA components with the 5'-ends complementary to the sequence of the polypodna will lead to hydrogel formation. This mixing strategy is useful when considering the incorporation of compounds into DNA hydrogels. Three types of hexapodna preparations, hexapodna(GpC) 8np-32 -A, hexapodna(GpC) 8np-32 -B and hexapodna(GpC) 8np-32 -C, were designed; the first two shared complementary 5'-ends (5'-tcctgacg-3' and 5'-cgtcagga-3'), whereas the 5'-ends of the third hexapodna were not complementary to either of the other oligonucleotides. Hydrogel formation in mouse skin after intradermal injection. Hexapodna(GpC) 8np-32 -A and hexapodna(GpC) 8np-32 -B (e, DNA hydrogel(GpC)) or hexapodna(GpC) 8np-32 -A and hexapodna(GpC) 8np-32 -C (f) was injected into the dorsal skin of mice at a dose of 30 mg/kg (660 g/mouse), and the skin was collected and observed at 3 h after injection.
Rapid recovery of the elasticity of DNA hydrogel on flow cessation. We next examined the rheological behavior of the DNA hydrogel(GpC). For each experimental run, the hydrogel was freshly prepared in a 29-gauge syringe at a total DNA concentration of 22.1 mg/ml (0.3 mM each ODN/ml) and charged in the rheometer.
Figures 2a and 2b, respectively, show the storage and loss moduli (G' and G'') of the hydrogel under oscillatory strain of various amplitudes ( 0 ) as indicated. In Figure 2b , the dotted curves indicate the G' data for  0 = 0.005 (0.5 %) and 0.1 (10%). For  0 ≤ 0.01 (1%), G' is independent of  0 and the angular frequency . Correspondingly, the loss modulus G" is much smaller than G', as noted from comparison of the triangles and upper dotted curve in Figure 2b . This linear elastic behavior, characterized by the equilibrium modulus G e = 1.1  10 3 Pa, indicates the solid-like feature of the hydrogel due to the physical network of hexapodna units not disputed under small strains.
In contrast, G' begins to decrease whereas G'' begins to increase with increasing  0 to 0.02 (2%). In particular, G'' becomes well above G' at the maximum strain amplitude examined,  0 = 0.1 (10 %), as noted from comparison of the filled squares and lower dotted curve in Figure 2b . These features reflect nonlinear flow of the hydrogel under large strains. In relation to this nonlinear flow, we also note that G' for  0 = 0.1 exhibits a minimum at  = 4 rad/s. This minimum, rarely observed for ordinary physiological gels [24] , suggests that the DNA hydrogel has a molecular process with a characteristic time  (in s) = 1/ = 0.25. The elasticity of the hydrogel is undoubtedly sustained by the physical network of hexapodna units, and the large strain should result in reorganization (disruption followed by reformation) of the network. This reorganization appears to occur at  = 0.25 s: For  below 1/, the network has a sufficient time to reform itself during one cycle of oscillation to exhibit larger G'. In contrast, for  above 1/, it has an insufficient time for disruption thereby exhibiting larger G'. The minimum of G' at  = 1/ possibly resulted from competition of such reformation and disruption processes. Consequently, Figure 2b shows the G''/G' ratio for  0 = 0.1 to become the largest at  = 1/, which suggests that an efficiency thermal dissipation of the mechanical energy reflected in this ratio becomes the highest when the network is most heavily disrupted.
The corresponding nonlinearity was noted also under constant-rate shear flow. Figure 2c ,  + deviates downward from the linear elastic line and decays to a steady state value  ss . This behavior reflects the "yielding" (switch from solid to fluid) under flow. In Figure 2d , those  ss values are plotted against the shear rate, . The  ss data approach a constant value of 13 Pa with decreasing , which indicates that the hydrogel has a dynamic yield stress,  y,dyn  13 Pa, being necessary for reorganizing the hydrogel under steady flow. The  y,dyn value is smaller than the static yield stress required for the network reorganization under slow strain,  y,dyn  32 Pa (estimated in Figure 2c as the stress at  =  *  0.03). Thus, the network appears to be scarcer under flow than at equilibrium. Nevertheless, oscillatory tests following the steady flow showed that the equilibrium network was recovered immediately after cessation of the flow. This rapid reformation and small value of  y,dyn enable easy injection of the DNA hydrogel into the mouse through the syringe and solidification immediately after the injection. Increased immunostimulatory activity of CpG DNA by hydrogel formation. We previously demonstrated that the immunostimulatory activity of CpG DNA is significantly increased by conversion into polypodna [14, 15, 17, 25] . To examine the immunostimulatory activity of DNA hydrogels, several forms of DNA samples were compared in terms of interleukin-6 (IL-6) release from mouse dendritic DC2.4 cells. Figure 3a shows the amount of IL-6 released from DC2.4 cells after addition of DNA samples at the indicated concentrations. Similar to the hexapodna preparations with no single stranded 5'-ends15, hexapodna(CpG) induced a greater amount of IL-6 production than ssDNA(CpG). At equimolar concentrations, DNA hydrogel(CpG) was significantly (P < 0.05) more potent than hexapodna(CpG) in inducing IL-6. GpC samples induced no detectable IL-6 production, irrespective of the structures. Tissue distribution of DNA hydrogel in mice. To trace the tissue distribution of DNA samples after injection into the dorsal skin of mice, ssDNA(CpG) 8np-32 -A1 was end-labeled with 32 P using [-
32 P]ATP and T4 polynucleotide kinase, and 32 P-labeled ssDNA(CpG), hexapodna(CpG), and DNA hydrogel(CpG) were prepared as described above. Figure 3b shows the time course of 32 P radioactivity in the dorsal skin of mice. After injection of 32 P-ssDNA(CpG) or 32 Phexapodna(CpG), 32 P radioactivity quickly disappeared from the injection site. In stark contrast, 32 P radioactivity remained at the injection site for a longer period after injection of 32 P-DNA hydrogel(CpG) with a half-life of about 12 h. The injection of 32 P-DNA hydrogel(CpG) resulted in a slow and sustained accumulation of 32 P radioactivity in the lymph nodes (Figure 3c ).
Correlation between tissue distribution of CpG DNA and elevated IL-6 expression. An injection of ssDNA(CpG) resulted in a slight increase in the mRNA expression (Figure 3d ). On the other hand, an injection of hexapodna(CpG) or DNA hydrogel(CpG) significantly increased the IL-6 expression at the injection site 6 h after injection. The expression remained high for the experimental period of 24 h only in the DNA hydrogel(CpG) group. Similar profiles of IL-6 mRNA expression were observed in the draining lymph nodes (Figure 3e ). There was no large increase in the IL-6 concentration in the serum after injection of DNA samples into the dorsal skin ( Figure S2 ), indicating that DNA hydrogel(CpG) induces IL-6 expression at local sites where they accumulate. Sustained release of OVA from DNA hydrogel. In order to visualize OVA release, we first encapsulated fluorescein isothiocyanate (FITC)-labeled OVA, a model antigen, into DNA hydrogel(CpG) consisting of hexapodna(CpG) 8np-32 -A and hexapodna(CpG) 8np-32 -B. Figure 4a shows the bright-field and fluorescent images of FITC-OVA/DNA hydrogel(CpG). The hydrogel was swollen for the first 1 h, and a yellow color representing FITC-OVA was gradually diluted with time. The fluorescent images clearly show the slow release of FITC-OVA from DNA hydrogel(CpG). The fluorescence intensity measurement showed that FITC-OVA was gradually released from the DNA hydrogel ( Figure 4b ) with a half-life of 2.5 h ( Figure S3 ). Figure 4c shows the degradation of DNA hydrogel(CpG) and hexapodna(CpG) 8np-32 -A in buffer solution with or without DNase I. DNA hydrogel(CpG) was much more resistant to degradation than hexapodna(CpG) 8np-32 -A. Figure  5d ). When OVA and DNA hydrogel(CpG) were administered separately to the dorsal skin (OVA) and to the footpad (DNA hydrogel), all the parameters examined were lower than those of the combined OVA/DNA hydrogel(CpG) group ( Figure S4 ). OVA/DNA hydrogel(CpG) induced no significant changes at the injection site or in spleen weight, in contrast to OVA injected with CFA or alum, which is used in some vaccine formulations ( Figure S5 ). 
DISCUSSION
Recent development of DNA nanotechnology has produced a large variety of DNA-based nanoand macrosystems [26] [27] [28] [29] . One such system is DNA hydrogel, and several groups, including ours, have reported preparative methods and applications of DNA hydrogel systems [16] [17] [18] [19] . The DNA-based material developed here was the hydrogel exhibiting the elasticity under small strain as shown in Figure 2a . In addition, the material did not flow with its own weight but was easily injected through a fine-gauged needle, which also indicates that the material is a gel. The DNA hydrogel developed in the present study has several unique and superior properties to other DNA hydrogels. First, it is injectable through an extra-fine, 29-gauge syringe. Injectable systems are much better than implantable ones when administered to patients. Second, no chemicals or synthetic compounds are needed for hydrogel preparation and gelation. Short DNA are the only components of the hydrogel, except for water and salts; this greatly enhances biocompatibility and biodegradability. Finally, hydrogel is an important system for sustained delivery of bioactive compounds [30] [31] [32] . Thus, the DNA hydrogel developed in this study provides a useful system for their sustained delivery. Some superior properties of the DNA hydrogel are attributed to the structural and thermal properties of nano-sized polypodna preparations that are designed and constructed using DNA nanotechnology. As demonstrated herein, DNA hydrogel can be developed either as an immunostimulatory system or in an immunologically inert mode.
The lower activity of hexapodna indicates that (1) DNA hydrogel is actually formed after injection, and (2) gel formation is important for the induction of OVA-specific immune responses. Clearance of topically injected DNA is mediated mainly by DNase-mediated degradation and by absorption into systemic circulation [33] . Gel formation interferes with the degradation because of the reduced free terminals as well as of steric hindrance. The absorption of compounds from the injection site is a function of molecular size, so that gel formation is a requisite for the slow clearance of DNA samples. At that point, OVA or other incorporated molecules can then be slowly released from the hydrogel. Since Liu et al. demonstrated that assembled antigen-CpG DNA complexes were useful for inducing antigen-specific antibody responses [34] , conjugates or complexes of OVA and CpG hexapodna may also be useful for the induction of OVA-specific immune responses. This possibility will be examined in future studies.
Crucially, we found that the DNA hydrogel undergoes very quick network reformation. Analysis of the modulus data suggested that the hydrogel is reorganized in a time scale of 0.25 s. This property is quite different from that of most hydrogel systems [24] . When the hydrogel is stressed, a fraction of the bonds is dissociated and, at the same time, the resulting free ends change partner and quickly reassociate through hydrogen bonds. This dissociation/association process allows the DNA hydrogel to be injected through an extra-fine needle and to return quickly to the gel state after injection.
The sharp difference between DNA hydrogel(CpG) and DNA hydrogel(GpC) clearly indicate that the recognition of CpG DNA by TLR9 is involved in the OVA-specific immune responses. Several studies using CpG DNA (which in most cases is phosphorothioate-modified) showed that the immunostimulation is important for antigen-specific immune responses [35] [36] [37] . The limited functions of ssDNA or hexapodna indicate that sustained OVA release is critical for induction of OVA-specific immune responses.
DNA hydrogel can be prepared from a wide variety of ODNs that can be custom-designed to fit the specific purpose. Thus, although our hydrogel described here was very effective, we cannot yet conclude that it is optimized for the induction of OVA-specific immune responses. This is since all the properties of DNA hydrogel, i.e., the immunostimulatory activity, the release rate of OVA, in vivo stability/degradation, are determined by its components. The optimization of these properties should be examined in future studies.
CONCLUSIONS
We have developed an injectable, self-gelling, biodegradable, and immunostimulatory DNA hydrogel using ODNs containing immunostimulatory CpG motifs, and proved that the hydrogel is an efficient system for sustained delivery of OVA, and for induction of the antigen-specific immune responses. Because the gel formation can be controlled by the salt concentration, the hydrogel can be delivered not only via injection but also packaged in spray or inhalation applications. 
